Thus, it needs a reliable control algorithm to combine multiple hypoglycemia prevention procedures such as initiation of glucagon when the blood glucose reaches the threshold (50–90 mg/dL), suspension and control insulin delivery, and escalation of alarms to remind the user [58, 59]. This evidence concerns the gene INS and Hypoglycemia.